Chemotherapy can change your body odor, and the effect is real rather than imagined. Some drugs are literally excreted through sweat glands, depositing traces of active compounds on the skin’s surface. Other treatment-related changes, from shifts in the skin’s bacterial community to secondary infections in skin folds, can produce new or stronger smells that patients and the people around them notice. Making things more complicated, chemotherapy often alters a patient’s own sense of smell, meaning the person undergoing treatment may perceive odors on themselves or in their surroundings far more intensely than before.
How Chemotherapy Drugs Reach Your Skin
Your skin is not just a passive barrier. The eccrine sweat glands, especially dense on your palms, soles, and underarms, continuously push fluid to the skin surface, and certain chemotherapy drugs hitch a ride. Researchers studying doxorubicin, one of the most widely used anthracycline chemotherapy agents, detected the drug deep inside sweat ducts and around their openings in the upper layers of skin. This finding confirmed that sweat acts as a carrier, transporting the drug from the bloodstream to the skin surface.1Annals of Oncology. Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome? The areas with the highest concentration of these glands, palms, soles, and armpits, are the same areas most commonly affected by the painful redness and peeling condition called hand-foot syndrome.
When a drug or its metabolic byproducts reach the skin surface through sweat, they can interact with bacteria already living there and with the compounds in sweat itself. This chemical interaction can produce volatile molecules that smell different from your normal body odor. Some patients describe the smell as metallic, others as medicinal or vaguely chemical. The specific character of the odor depends on the drug, the individual’s metabolism, and the bacteria colonizing their skin. The point is that this is not a subtle or theoretical pathway. Your body is actively pushing drug residues outward through sweat, and the nose can sometimes detect the results.
Skin Microbiome Disruption and Infections
Chemotherapy suppresses the immune system broadly, and that includes local immune defenses in the skin. The community of microorganisms living on your skin, what researchers call the skin microbiome, can shift during cancer treatment. These shifts have been linked to the development and severity of treatment-related skin problems, including hand-foot syndrome from chemotherapy and radiation-related skin inflammation.2PubMed Central. Skin Microbiome and Treatment-Related Skin Toxicities in Patients With Cancer: A Mini-Review When the normal balance of skin bacteria and fungi is disrupted, opportunistic organisms can move in, and the metabolic byproducts of those organisms often smell quite different from what you are used to.
One specific and often overlooked source of odor during chemotherapy is intertrigo, a condition where skin-on-skin contact in folds, such as under the breasts, in the groin, or in the armpits, creates a warm, moist environment ripe for infection. In cancer patients whose immune systems are already compromised, intertrigo can become complicated by secondary bacterial or fungal infections. When that happens, the affected skin can develop maceration, oozing, crusting, and a noticeable odor.3Edorium Journals. A case series of intertriginous rashes in cancer patients This is distinct from the chemical smell of drug excretion. It is the smell of a localized infection, and it can be quite strong. Patients who notice a sudden, pungent smell concentrated in a skin fold should mention it to their care team, because it often signals a treatable secondary infection rather than just a cosmetic nuisance.
The DMSO Factor in Stem Cell Transplants
One of the most dramatic odor experiences in cancer treatment has nothing to do with the chemotherapy drug itself and everything to do with a substance used as a preservative. Dimethyl sulfoxide, commonly called DMSO, is used to preserve stem cells during the freezing process in peripheral stem cell transplants. When those preserved cells are infused back into a patient, the DMSO enters the bloodstream and is rapidly excreted through the lungs and skin, producing a powerful garlic- or corn-like smell that can fill an entire hospital room.
The odor is so intense and persistent that nursing staff have raised formal concerns about it. In a study that interviewed 22 oncology nurses who had experience caring for patients receiving DMSO-containing infusions, 20 of the 22 described the odor as unpleasant. Many reported physical symptoms from the exposure, including headaches and gastrointestinal reactions.4PubMed. Oncology nurses’ experience of dimethyl sulfoxide odor The smell can linger on the patient’s breath and skin for one to two days after the infusion. Patients and their families are usually warned about this ahead of time, but the intensity still catches many off guard. If you are going through a stem cell transplant, this is a temporary and expected side effect of the preservation process, not a sign that anything has gone wrong.
When Your Own Sense of Smell Changes
Here is a wrinkle that complicates the whole picture. Chemotherapy frequently alters the patient’s own sense of smell, sometimes dramatically. A survey of 518 patients receiving outpatient chemotherapy in Sweden found that about 8% reported smell changes specifically. Among those patients, every single one described increased sensitivity to odors rather than decreased sensitivity. The heightened smell was often unpredictable, arriving and departing without a clear pattern, and it led to significant emotional distress.5European Journal of Oncology Nursing. Olfactory changes among patients receiving chemotherapy
This means that some patients who report new or stronger body odor during treatment are experiencing a real change in their own smell, but others may be detecting odors that were always present at low levels and are now amplified by a chemically sensitized nose. Both situations are real and distressing. For the person going through it, the distinction matters less than the daily experience of being overwhelmed by smells that previously went unnoticed. Cooking odors, perfumes, cleaning products, and yes, their own body, can suddenly become intolerable. This heightened perception typically fades after treatment ends, but it can persist for weeks to months into the recovery period.
The overlap between actual odor production and altered odor perception makes this topic hard to study cleanly. A patient may genuinely be excreting drug metabolites through their sweat and simultaneously perceiving that excretion more intensely than they normally would. Both factors reinforce each other, creating an experience that feels overwhelming but is often dismissed by those around the patient who may not smell anything unusual.
Which Drugs Are Most Associated With Smell and Taste Problems
Not all chemotherapy regimens are equally likely to cause odor-related problems. The drugs most frequently linked to taste and smell disturbances, which often travel together, include docetaxel, paclitaxel, nab-paclitaxel, capecitabine, cyclophosphamide, epirubicin, other anthracyclines, and oral 5-FU analogues.6PubMed Central. Taste and Smell Disorders in Cancer Treatment: Results from an Integrative Rapid Systematic Review These are among the most commonly used chemotherapy agents worldwide, which means a large proportion of patients receiving standard treatment are exposed to at least one drug on this list.
The connection between taste and smell changes and body odor is indirect but meaningful. Drugs that alter how your body processes volatile compounds, the airborne chemicals your nose detects, are also drugs whose metabolites are more likely to show up in sweat, breath, and urine in detectable quantities. Cyclophosphamide, for instance, is well known among patients and nurses for giving urine a strong, distinctive chemical smell during infusion and for days afterward. Anthracyclines like doxorubicin and epirubicin, as mentioned earlier, have been detected in sweat itself. If your treatment includes one of these drugs and you notice a new body smell, there is a straightforward chemical reason for it.
What You Can Do About It
Understanding why the odor happens matters because it points toward specific strategies that actually help. The approaches depend on which mechanism is driving the problem.
For odor related to drug excretion through sweat, the single most accessible intervention is staying well hydrated. Higher fluid intake dilutes the concentration of drug metabolites in sweat and urine, which can reduce the intensity of the smell. Frequent, gentle bathing helps clear drug residues from the skin surface before they have time to interact with skin bacteria and produce volatile compounds.
For skin-related odor from microbiome disruption or secondary infections, skin care matters more than you might expect. A study tested whether using an acidic washing product and an acidic moisturizer, both at a pH of 5.5, could improve skin condition in chemotherapy patients. After three weeks of consistent use, the patients showed significantly improved skin hydration, restored barrier function, and higher sebum levels. All skin symptoms the researchers tracked improved considerably.7Skin Pharmacology and Physiology. Functional Assessment of a Skin Care System in Patients on Chemotherapy A healthier skin barrier supports a more stable microbial community, which in turn reduces the conditions that lead to odor-producing infections. The key detail here is the acidity: mildly acidic products maintain the skin’s natural acid mantle, which helps keep opportunistic bacteria and fungi in check.
For infections in skin folds that are producing noticeable odor, keeping those areas clean and dry is essential. Absorbent powders and barrier creams can help, but if the smell is strong or the skin looks inflamed, weepy, or crusted, it is worth bringing it up with your oncology team. A short course of antifungal or antibacterial treatment often resolves the problem quickly. Many patients hesitate to mention body odor to their doctors, treating it as an embarrassing side effect rather than a medical symptom. But odor from skin folds during chemotherapy is a clinical finding that can guide treatment decisions.
When Other People Can and Cannot Smell It
Patients often worry about whether the people around them can detect the changes they are noticing. The answer varies by mechanism. Drug excretion through sweat produces subtle odor changes that close contacts sometimes pick up but strangers in a room generally do not, unless the person is sweating heavily. The DMSO smell from stem cell transplant infusions, on the other hand, is unmistakable and noticeable from across a room. Odor from infected skin folds tends to be localized and detectable mainly during intimate contact or when the area is exposed.
The heightened smell sensitivity that chemotherapy produces creates an asymmetry that can be isolating. The patient may find their own body odor overwhelming and assume everyone else must notice it too, while family members and friends genuinely cannot detect anything unusual. This gap can lead to social withdrawal, reluctance to go out, and significant anxiety. If someone you know is going through chemotherapy and mentions being self-conscious about their smell, take the concern seriously. Reassurance that you cannot detect an odor is helpful, but so is acknowledging that what they are experiencing is real to them and not a sign of poor hygiene or overreaction.
Odor Changes After Treatment Ends
For most patients, body odor changes during chemotherapy are temporary. Once the drug clears the body, the excretion through sweat stops. The skin microbiome gradually rebalances as the immune system recovers. Infections resolve with treatment or with the return of normal immune surveillance. Smell sensitivity fades, usually within a few months of completing chemotherapy, though some patients report lingering hypersensitivity for longer.
The timeline depends partly on which drugs were used and how many cycles were administered. Patients who received highly emetogenic regimens over many months tend to report more persistent sensory changes, including both taste and smell disturbances, than those who had shorter courses. There is wide individual variation, and no reliable way to predict ahead of time how long any one person’s odor or sensory changes will last. What the evidence does support is that the changes are overwhelmingly reversible. The handful of patients who experience longer-lasting smell sensitivity generally see gradual improvement over six to twelve months.
One lingering effect that surprises some people is conditioned aversion. Patients who associate certain smells, including their own body odor during treatment, with nausea and distress can develop lasting emotional reactions to those smells long after the chemical cause has resolved. The smell itself may no longer be present, but encountering something reminiscent of it can trigger a strong negative response. This is a well-recognized phenomenon in oncology, closely related to the anticipatory nausea that develops in some patients. It is a learned response, not a sign that treatment effects are lingering, and it tends to fade with time and exposure.